FI832922A0 - 1-fenetyl- -fenylpiperidin-3-propannitrilderivat, deras framstaellning och terapeutiska tillaempning - Google Patents

1-fenetyl- -fenylpiperidin-3-propannitrilderivat, deras framstaellning och terapeutiska tillaempning

Info

Publication number
FI832922A0
FI832922A0 FI832922A FI832922A FI832922A0 FI 832922 A0 FI832922 A0 FI 832922A0 FI 832922 A FI832922 A FI 832922A FI 832922 A FI832922 A FI 832922A FI 832922 A0 FI832922 A0 FI 832922A0
Authority
FI
Finland
Prior art keywords
radical
propannitril
tillaempning
phenylpiperidine
phenethyl
Prior art date
Application number
FI832922A
Other languages
English (en)
Other versions
FI832922A (fi
Inventor
Philippe Manoury
Jean Binet
Gerard Defosse
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI832922A0 publication Critical patent/FI832922A0/fi
Publication of FI832922A publication Critical patent/FI832922A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
FI832922A 1982-08-16 1983-08-12 1-fenetyl- -fenylpiperidin-3-propannitrilderivat, deras framstaellning och terapeutiska tillaempning FI832922A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8214154A FR2531702A1 (fr) 1982-08-16 1982-08-16 Derives de phenethyl-1a-phenylperidine-3-propanenitrile, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FI832922A0 true FI832922A0 (fi) 1983-08-12
FI832922A FI832922A (fi) 1984-02-17

Family

ID=9276888

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832922A FI832922A (fi) 1982-08-16 1983-08-12 1-fenetyl- -fenylpiperidin-3-propannitrilderivat, deras framstaellning och terapeutiska tillaempning

Country Status (19)

Country Link
US (1) US4481207A (fi)
EP (1) EP0103500B1 (fi)
JP (1) JPS5953467A (fi)
AT (1) ATE31924T1 (fi)
AU (1) AU559173B2 (fi)
CA (1) CA1239406A (fi)
DE (1) DE3375299D1 (fi)
DK (1) DK367983D0 (fi)
ES (1) ES8404329A1 (fi)
FI (1) FI832922A (fi)
FR (1) FR2531702A1 (fi)
GR (1) GR78689B (fi)
HU (1) HU190729B (fi)
IL (1) IL69490A (fi)
MX (1) MX155971A (fi)
NO (1) NO832897L (fi)
NZ (1) NZ205250A (fi)
PT (1) PT77194B (fi)
ZA (1) ZA835970B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932594A (en) * 1988-11-01 1999-08-03 Pfizer, Inc. Muscarinic receptor antagonists
GB8825505D0 (en) * 1988-11-01 1988-12-07 Pfizer Ltd Therapeutic agents
FR2676053B1 (fr) * 1991-05-03 1993-08-27 Sanofi Elf Nouveaux composes dialkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB930459A (en) * 1963-09-26 1963-07-03 Aspro Nicholas Ltd Diphenyl methane derivatives and methods for the preparation thereof
GB1057145A (en) * 1963-08-16 1967-02-01 Bellon Labor Sa Roger Phenylcyclohexylacetonitrile derivatives
FR2302739A1 (fr) * 1975-03-03 1976-10-01 Synthelabo Nouveaux derives du phenyl-2(piperidinyl-4)-2 acetonitrile, leurs sels, leur preparation et les medicaments qui en contiennent
US4399286A (en) * 1981-07-16 1983-08-16 Mead Johnson & Company Antiarrhythmic phenethylpiperidine compounds

Also Published As

Publication number Publication date
FI832922A (fi) 1984-02-17
GR78689B (fi) 1984-09-27
JPS5953467A (ja) 1984-03-28
AU559173B2 (en) 1987-02-26
MX155971A (es) 1988-06-03
PT77194B (fr) 1986-03-21
ZA835970B (en) 1984-04-25
ES524907A0 (es) 1984-05-01
US4481207A (en) 1984-11-06
ATE31924T1 (de) 1988-01-15
DE3375299D1 (en) 1988-02-18
NZ205250A (en) 1985-07-31
HU190729B (en) 1986-10-28
CA1239406A (en) 1988-07-19
EP0103500A2 (fr) 1984-03-21
PT77194A (fr) 1983-09-01
FR2531702A1 (fr) 1984-02-17
NO832897L (no) 1984-02-17
EP0103500A3 (en) 1984-11-28
AU1793483A (en) 1984-02-23
FR2531702B1 (fi) 1984-12-07
DK367983D0 (da) 1983-08-12
JPS6125708B2 (fi) 1986-06-17
EP0103500B1 (fr) 1988-01-13
IL69490A (en) 1986-11-30
ES8404329A1 (es) 1984-05-01

Similar Documents

Publication Publication Date Title
FI900760A0 (fi) Benzensulfonamider och foerfarande foer deras framstaellning.
DK352482A (da) Fremgangsmaade til fremstilling af 1-phenyl-2-aminocarbonylindol-forbindelser og mellemprodukter til brug herved
FI833075A (fi) 2-nitro-1,1-etendiaminer, foerfaranden foer deras framstaellning och deras anvaendning som laekemed
FI832922A (fi) 1-fenetyl- -fenylpiperidin-3-propannitrilderivat, deras framstaellning och terapeutiska tillaempning
FI852647A0 (fi) 3-aminokarbonylmethoxy-5-fenylpyrazol- foereningar och foerfarande foer deras framstaellning och laekemedel som innehaoller dessa foereningar.
MX9102667A (es) Mejoras en compuestos farmacologicamente activos y procedimiento para la preparacion de dichos compuestos.
FI842360A (fi) Nya 1-acetonyl-2-(fenylimino)-imidazo lidiner, deras syraadditionssalter, dessa innehaollande laekemedel och foerfarande foer deras framstaellning.
FI821288L (fi) Fenetanolaminderivat, deras framstaellning och deras terapeutiska anvaendning
FI843785L (fi) 2-(n-pyrrolidino)-3-isobutoxy-n- substituerade fenyl-n-benzyl-propylaminer, deras framstaellning och farmaceutiska anvaendning.
DK274082A (da) Fremgangsmaade til fremstilling af 2-acylaminomethyl-1,4-benzodiazepin-forbindelser og mellemprodukter til brug herved
DK285683A (da) Fremgangsmaade til fremstilling af substituerede phenylpiperazinforbindelser
ATE61585T1 (de) N-carboxyalcoyl-2-oxo-3-diaryl-5-6 triazine als heilmittel.
IT1150206B (it) Procedimento per la preparazione di 2-(4-aroilpiperazin-1il)-ammino-6,7-dimetossichinazoline ipotensive,
SE8105297L (sv) Imidazolderivat

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SYNTHELABO